News

23andMe, Inc.: 23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. ("23andMe" or the "Company") (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file ...
23andMe to voluntarily delist from Nasdaq, deregister with SEC
Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading ...
NBC Los Angeles6d
23andMe to delist from Nasdaq, deregister with SEC
Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 ...
11Alive14d
23andMe finds a buyer two months after bankruptcy filing
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...